All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Intraocular lenses (“IOL”) may comprise one or more fluids disposed therein. For example, some accommodating IOLs use fluid movement within the IOL, or a change in fluid pressure within the IOL, to effect optical power change in the IOL. Exemplary accommodating IOLs that include a fluid can be found in U.S. Pat. App. Pub. Nos. 2008/0306588, filed Jul. 22, 2008, and 2008/0306587, filed Jul. 22, 2008, the disclosures of which are incorporated herein by reference. Exemplary methods of accommodation in response to natural ciliary muscle movement are also described therein. For example, in the embodiment shown in FIGS. 3-5 in U.S. Pat. App. Pub. No. 2008/0306588, a fluid pressure increase in the optic portion causes the shape of the anterior surface of the optic portion to change, thereby changing the power of the lens. Silicone oil is an example of a fluid that can be used in an IOL. In the embodiment shown, the peripheral portion is in fluid communication with the optic portion, allowing, for example, silicone oil to flow between the optic portion and the peripheral portion. The bulk material of the lens includes anterior lens element 16, intermediate layer 18, and posterior element 22. The bulk material can also be considered to include the haptic bulk material in the peripheral portion of the IOL.
When fluids such as silicone oil are used in an accommodating intraocular lens, the fluid, over time, may tend to swell into the bulk material. This can reduce the amount of silicone oil available to drive the optical power change in the IOL. It is therefore desirable to minimize the amount of swelling into the bulk material. It may also be important to provide silicone oil that does not reduce the response time of the accommodating IOL.
Some IOLs rely on, or can benefit from, a substantially uniform refractive index throughout the IOL. It may therefore also be beneficial to provide silicone oil that has a refractive index that is as close to the refractive index of the bulk material as possible.
Improved fluids (e.g., silicone oils), their methods of manufacture, and their methods of use in accommodating intraocular lenses are therefore needed.
One aspect of the disclosure is a method of manufacturing silicone oil for use in an intraocular lens, comprising purifying silicone oil to be used in an intraocular lens, wherein the silicone oil has a polydispersity index of less than about 1.5, and in some embodiments less than about 1.3. The silicone oil can have a mean molecular weight of between about 5000 Daltons and about 6500 Daltons. In some embodiments there is no more than about 50 ppm of any low molecular weight component, such as components that have a molecular weight of about 1000 Daltons or less, in the silicone oil to be used in the intraocular lens. In some embodiments the method includes controlling the refractive index of the silicone oil to be between about 1.47 and about 1.49. In some embodiments purification step is a supercritical CO2 extraction, while in some embodiments it is a wiped-film extraction. The purification step substantially prevents the silicone oil from swelling in a bulk polymeric material of the intraocular lens. In some embodiments the silicone oil comprises diphenyl siloxane and dimethyl siloxane, and in some particular embodiments there is about 20% diphenyl siloxane and about 80% dimethyl siloxane.
One aspect of the disclosure is a method of manufacturing silicone oil for use in an intraocular lens, comprising synthesizing silicone oil to be used in an intraocular lens, wherein the silicone oil has a polydispersity index of less than about 1.5. The synthesis can be a living polymerization synthesis. The method also includes a purification step after the synthesis step, which can be, for example, a supercritical CO2 extraction or a wiped-film purification step. In some embodiments the silicone oil has a mean molecular weight of between about 5000 Daltons and about 6500 Daltons. In some embodiments there is no more than about 50 ppm of any low molecular weight component in the silicone oil. In some embodiments the viscosity of the silicone oil is less than about 1000 cSt at about 25° C.
One aspect of the disclosure is a method of manufacturing silicone oil for use in an intraocular lens, comprising purifying silicone oil to be used in an intraocular lens, wherein the silicone oil has a mean molecular weight between about 5000 Daltons and about 6500 Daltons. The silicone oil can have a polydispersity index of less than about 1.5. In some embodiments there is no more than about 50 ppm of any low molecular weight component in the silicone oil. The manufactured silicone oil is adapted to avoid swelling in a bulk polymeric material of the intraocular lens. The silicone oil can comprise diphenyl siloxane and dimethyl siloxane.
One aspect of the disclosure is a method of manufacturing an intraocular lens, comprising providing a silicone oil that has been purified to have a polydispersity index of less than about 1.5; and assembling a bulk polymer material and the silicone oil to form an intraocular lens. The assembling step can comprise advancing the silicone oil into a fluid chamber within the bulk material of the intraocular lens. The silicone oil can have been purified to have a mean molecular weight between about 5000 Daltons and about 6500 Daltons. The silicone oil can have been purified such that there is no more than 50 ppm of any component that has a molecular weight of about 1000 Daltons or less. In some embodiments the silicone oil has been substantially index-matched to at least a portion of the bulk material.
One aspect of the disclosure is a method of using an intraocular lens: comprising creating an opening in the eye; and implanting in a posterior chamber of an eye an intraocular lens comprising silicone oil purified to have a polydispersity index of less than about 1.5.
One aspect of the disclosure is silicone oil adapted to be used in an intraocular lens, wherein the silicone oil has been purified and has a polydispersity index less than about 1.5. The silicone oil can comprise diphenyl siloxane and dimethyl siloxane, and in some embodiments the silicone oil comprises about 20 mol % diphenyl siloxane and about 80% dimethyl siloxane. The silicone oil can have a mean molecular weight between about 5000 Daltons and about 6500 Daltons, and there are no more than 50 ppm of any component that has a molecular weight of about 1000 Daltons or less. In some embodiments the silicone oil has a viscosity of less than about 1000 cSt at about 25° C. The refractive index can be between about 1.47 and about 1.49.
One aspect of the disclosure is silicone oil adapted to be used in an intraocular lens, wherein the silicone oil has been synthesized and has a polydispersity index less than about 1.5.
One aspect of the disclosure is an accommodating intraocular lens comprising a bulk polymeric material and silicone oil that has a polydispersity index less than about 1.5. The silicone oil can have an index of refraction between about 1.47 and about 1.49. The silicone oil can comprise diphenyl siloxane and dimethyl siloxane. The silicone oil can have a mean molecular weight number average of between about 5000 Daltons to about 6500 Daltons. The viscosity of the oil can be less than about 1000 cSt at about 25° C. In some embodiments there is no more than 50 ppm of any component that has a molecular weight of about 1000 Daltons or less.
The disclosure herein generally relates to fluid, such as silicone oil, that is used in an intraocular lens. In some embodiments the silicone oil is used in an accommodating intraocular lens that uses fluid movement to effect optical power change in the IOL. The silicone oil can, however, be used in non-accommodating intraocular lenses as well.
Accommodating IOLs can utilize the eye's natural ciliary muscle movements to provide accommodation in the IOL. For example, some accommodating IOLs are implanted within a patient's capsular bag (after the native lens has been removed) and respond to capsular bag reshaping to change the power of the lens. Some IOLs are designed to be implanted outside of the lens capsule and accommodate in other ways. Whatever the method of accommodation, silicone oil disposed within an accommodating IOL can be adapted to be moved within the IOL in response to the eye's natural movement in order to change the lens power. Properties of the silicone oil can therefore affect the accommodative response time of the IOL. The selected silicone oil therefore does not undesirably hinder the response time of the IOL.
When silicone oil is used in accommodating IOL with a bulk material such as a polymeric material, some of the oil components can pass into the bulk material, causing the bulk material to swell. The selected silicone oil or oils therefore avoids the undesirable swelling of the bulk polymer. Exemplary polymeric materials that can be used for the bulk material of the IOL can be found in U.S. application Ser. No. 12/177,720, filed Jul. 22, 2008, and in U.S. application Ser. No. 12/034,942, filed Feb. 21, 2008, the disclosures of which are incorporated herein by reference.
One characteristic of silicone oil that helps ensure an adequate response and avoids undesirable swelling is the polydispersity index (“PDI”) of the silicone oil to be used in the IOL. PDI is generally a measure of the distribution of molecular mass in a given sample. A relatively low PDI indicates a relatively narrow range of molecular weights. The silicone oils described herein have a PDI less than about 1.5, and more particularly less than or equal to about 1.3.
A second characteristic of the silicone oil that helps ensure an adequate response and avoids undesirable swelling is the mean molecular weight of the silicone oil. When high concentrations of relatively low molecular weight components are present in the silicone oil, a greater number of low molecular weight components pass into the bulk material of the IOL causing the swelling of the bulk material. To avoid undesirable swelling, the concentration of relatively low molecular weight components should be minimized. By reducing the concentration of relatively low molecular weight components and maintaining a high concentration of relatively high molecular weight components, fewer low molecular weight components will pass into the bulk polymer material, reducing the amount of swelling that occurs in the bulk material.
The PDI of the silicone oil and the mean molecular weight of the oil are related—by lowering the PDI of the silicone oil while providing silicone oil with high concentrations of relatively high molecular weight components and low concentrations of low molecular weight components, the response of the IOL is maintained (by providing a silicone oil with suitable viscosity) and undesirable swelling is avoided. Additionally, providing silicone oil with a low PDI and very low concentrations of small molecular weight components means that the silicone oil has a molecular weight just large enough to avoid swelling of the polymer.
In some embodiments silicone oil is provided that has a mean molecular weight between about 5000 and about 6500 Daltons, which is large enough to substantially avoid swelling of the bulk polymeric material. This is preferable to the alternative, which is using a higher molecular weight silicone oil which has inherently fewer small molecule components because almost all molecules comprising it are large. High molecular weight silicone oils can have a correspondingly high viscosity, which can reduce the response time of the accommodating IOL.
The silicone oils described herein have a very low concentration of relatively low molecular weight components. The very low molecular weight components are present in an amount less than about 200 ppm of each component, and in some embodiments less than about 100 ppm. In some particular embodiments the very low molecular weight components are present in an amount less than about 50 ppm.
The relatively low molecular weight components include those less than or equal to about 1000 Daltons. For example, in some embodiments the concentration of components less than or equal to about 1000 Daltons is not more than about 50 ppm.
In one particular embodiment, silicone oil is provided in which no more than 20% of the total silicone by weight is comprised of components below about 4000 Daltons; no more than 10% of the total polymer fluid by weight is comprised of components below 3000 Daltons; and no more than 50 ppm of any components below 1000 Daltons.
The estimated molecular weights and polydispersities described herein are relative to polystyrene molecular weights standards.
The silicone oil generally needs to be designed in such a way as to avoid adverse interactions with the surrounding bulk IOL material, such as swelling, fogging, dissolving or reacting with the material (e.g., poly acrylate) in some IOLs. The degree of solubility of the silicone oil in the bulk material is dependent on the chemical structure and molecular weight distribution of the silicone oil. Other parameters that influence this interaction are the composition and properties of the bulk material such as homogeneity, chemical structure, hydrophobicity, modulus, and crosslink density.
The viscosity of the silicone oil also generally needs to be defined and minimized because, in embodiments in which the fluid-driven accommodating IOL operates dynamically, the IOL must have an appropriate response time. In some embodiments the viscosity of the silicone oil is less than about 1000 cSt at 25° C.
In some embodiments the silicone oil is comprised of diphenyl siloxane and dimethyl siloxane. In some embodiments the oil is a diphenyl siloxane and dimethyl siloxane copolymer with about 20 mol % diphenyl siloxane and about 80 mol % dimethyl siloxane.
In some IOLs it may be desirable to avoid creating an optical interface between the bulk material of the IOL and the silicone oil within the IOL. This can be done by index-matching the silicone oil to the bulk material of the IOL, which in some embodiments is a polymeric material. “Index-matching” as used herein refers to minimizing the optical interface between first and second media. For example, index-matching silicone oil and a polymeric material refers to attempting to eliminate an optical interface therebetween, and “substantially the same” refers to indexes of refraction that, even though they may be slightly different, are intended to be as close as possible to minimize the difference in refractive indexes.
In some embodiments in which the silicone oil is index-matched to the bulk polymeric material, the refractive index of silicone oil is between about 1.47 and about 1.53, and in some embodiments is between about 1.47 and about 1.49.
In some embodiments the silicone oil must be able to be filtered through an about 0.7 micron filter. In some embodiments the percent volatiles are less than about 0.2%. In some embodiments the silicone oil has a chromatic dispersion less than or equal to about 0.035 refractive index units in the visible range of 400 nm to 750 nm at 35° C. In some embodiments the silicone oil components are fully miscible with each other without evidence of phase separation (i.e. cloudiness or suspensions). In some embodiments the silicone oil has greater than 85% transmittance in the range of 400 nm to 1100 nm for about a 1 cm thick fluid sample.
In addition, the silicone oil should be clear, colorless, have less than about 10 ppm heavy metals and other insoluble inorganics contaminants, and have substantially no silanols.
Synthesis
The molecular weight, polydispersity, and in some instances the refractive index of the silicone oil can be controlled by the way in which the silicone oil is synthesized and purified. The viscosity of the oil is related to the molecular weight of the oil, the polydispersity of the oil, and the architecture of the bulk polymer, all of which are influenced by the synthesis and purification of the polymer. However, a target viscosity can not be arbitrarily selected independent of the target molecular weight, polydispersity, composition, and architecture of the silicone oil. A general class of polymer synthesis reactions known as “living polymerization reactions” can offer the degree of control necessary to assist in meeting some of the design requirements for a silicone oil.
The term “living polymerization” implies a polymerization reaction that does not have a significant number of chain terminating or chain transferring side reactions. The absence of side reactions allows living polymerizations to be used to synthesize a variety of materials that would be otherwise difficult to prepare. This class of polymerization reactions can be used to prepare polymers with a variety of 1) architectures—including linear, “star”, and “comb” polymers; 2) compositions—homopolymers, random copolymers, block copolymers, and graft copolymers; and 3) functionalized polymers—one and two end functional polymers, and side functional polymers. This class of polymerization reactions can be used to prepare polymers that often have a narrow molecular weight distribution and at a variety of molecular weights. As a result, living polymerizations are often employed when polymers with specific structures and compositions are needed. For example, a polymer with a large molecular weight distribution can be considered to be a mixture of a large number of compounds, and the properties of the material are some function of that distribution. Polymers that have a small molecular weight distribution, however, as can result from a living polymerization, can be considered a “purer” sample, with properties that are better defined.
Anionic and cationic living polymerizations have been described in the art. More recently, radical living polymerizations may have been developed. In an example of an anionic synthetic route, the use of alkyl lithium compounds in the ring opening polymerization of cyclotrisiloxanes appears to be a “living” polymerization, allowing for the degree of control needed to make the silicone oils described above. By varying the ratio of phenyl containing cyclotrisiloxanes to methyl only containing cyclotrisiloxanes (that is, preparing a random block copolymer), the refractive index of the silicone oil can be varied between the refractive index of either pure homopolymer alone (i.e., between pure diphenyl polysiloxane and pure dimethyl polysiloxane).
As another example, the refractive index of the silicone oil can be varied by varying the ratio of a tetramethyl-diphenyl-cyclotrisiloxane to hexamethyl cyclotrisiloxanes. Varying this ratio can provide different refractive indexes between about 1.40 and about 1.54, including those between about 1.47 and 1.49.
As mentioned above, a living polymerization also offers the advantage of being able to prepare polymer products of a targeted molecular weight. This can be accomplished by varying the monomer to initiator ratio during the polymerization reaction, an application which can be applied to the preparation of silicone oils of a specified formula weight.
The feature of a narrow range of molecular weight products is also an advantage that can be realized in the preparation of silicone oils because fewer low molecular weight oligomers are made during the polymerization reaction. The smaller quantity of the low molecular weight materials prepared minimizes the amount of purification that needs to occur later to remove them from the higher molecular weight products. For example, when fewer low molecular weight oligomers are made during the polymerization reaction, it is easier to extract the low molecular weight materials when purifying the synthesized silicone oil using a supercritical CO2 extraction (described below), resulting in higher yields of the desired product.
While the viscosity of a polymer is not directly related to the way in which the polymer is prepared, a living polymerization can also be used to indirectly modify this feature of the product polymer. Living polymerizations can be used to make polymer architectures that would be difficult to accomplish using other synthetic strategies. For example, “comb” polymers, “star” polymers, and other branched structures can be prepared, which, even though they have a very similar chemical composition to a “linear” polymer, may have different physical properties (e.g., viscosity), because of the different physical geometries those structures have. Preparation of a highly branched silicone oil may yield a product which has a significantly lower viscosity than a silicone oil with the same molecular weight but a linear structure.
Silicone oils can also be prepared using other synthetic strategies such as the base catalyzed ring opening of cyclotrisiloxanes, and the condensation of dialkyldichloro silanes with water. These synthetic strategies can also prepare silicone oils with many of the characteristics described above, but can require more effort on purification.
Purification
Silicon oils can be purified in a variety of ways. Wiped film evaporation can be used to remove low molecular weight compounds that have a high boiling point. The silicone oil product may, however, be discolored on excessive heating when using wiped film evaporation.
Supercritical CO2 extraction is one exemplary purification method that can be used to selectively remove fractions of silicone oil based on molecular weight and based on chemical affinity. Supercritical CO2 extraction to purify silicone oils to produce silicone vitreoretinal tamponades is described in U.S. Pat. No. 7,276,619, the entire disclosure of which is incorporated by reference herein. These oils are not used for IOLs, are particularly not in fluid-drive accommodating IOLs. Pressure, temperature, rate of extraction conditions, and the use of co-eluting solvents such as, for example, acetone, can be varied to yield fractions that have a narrow molecular weight distribution (i.e., a low PDI). A mixture can be separated in such a way as to strip the very low and very high molecular fractions from a sample achieving the desired molecular weight. Because supercritical extraction conditions can be varied to get separation based on chemical affinity, this purification method can also be used to achieve a desired refractive index. Supercritical CO2 extraction can therefore be used to produce a silicone oil with, for example, an index of refraction substantially the same as a bulk polymer to be used in an intraocular lens (e.g., in a fluid-driven accommodating intraocular lens).
Tables 1-3 provide data from exemplary supercritical CO2 extractions of sample silicone oils.
Similarly, preparative scale size exclusion chromatography is an alternative method to fractionate a polymer sample into molecular weight components. Fractional precipitation of the silicone oil may also be used to separate components of the product polymer.
Removal of silicone oil components that dissolve into the bulk IOL material over time (e.g., during storage) may also be accomplished by exposing the silicone oil to bulk quantities of the IOL material, or other materials that have been selected for that purpose. On storage with an appropriate material, the components of the silicone oil that dissolve into the bulk IOL polymeric material may be removed by adjusting the ratio of silicone oil to polymer adsorbent so that sufficiently low levels of those materials remain in the oil.
While silicone oils used in accommodating IOLs are primary described herein, it is possible to use any of the silicone oils in a non-accommodating IOL. For example, a non-accommodating IOL can have a relatively rigid outer polymeric shell surrounding a silicone oil core. Swelling of the bulk polymeric material would still need to be taken into consideration, and hence the methods of manufacturing desired silicone oil described herein could be utilized.
This application is a continuation of U.S. application Ser. No. 14/555,001, filed Nov. 26, 2014, now U.S. Pat. No. 10,980,629, which is a continuation of U.S. application Ser. No. 13/033,474, filed Feb. 23, 2011, now U.S. Pat. No. 8,900,298, which application claims the benefit of U.S. Provisional Patent Application No. 61/307,354, filed Feb. 23, 2010, the disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4111995 | Nelson | Sep 1978 | A |
4251887 | Anis | Feb 1981 | A |
4253199 | Banko | Mar 1981 | A |
4254509 | Tennant | Mar 1981 | A |
4304895 | Loshaek | Dec 1981 | A |
4373218 | Schachar | Feb 1983 | A |
4409691 | Levy | Oct 1983 | A |
4423809 | Mazzocco | Jan 1984 | A |
4435855 | Pannu | Mar 1984 | A |
4435856 | L'esperance | Mar 1984 | A |
4466705 | Michelson | Aug 1984 | A |
4490860 | Rainin | Jan 1985 | A |
4494254 | Lopez | Jan 1985 | A |
4512040 | Mcclure | Apr 1985 | A |
4528311 | Beard et al. | Jul 1985 | A |
4575373 | Johnson | Mar 1986 | A |
4585457 | Kalb | Apr 1986 | A |
4604295 | Humphreys | Aug 1986 | A |
4615701 | Woods | Oct 1986 | A |
4620954 | Singer et al. | Nov 1986 | A |
4685921 | Peyman | Aug 1987 | A |
4685922 | Peyman | Aug 1987 | A |
4693717 | Michelson | Sep 1987 | A |
4720286 | Bailey et al. | Jan 1988 | A |
4731078 | Stoy et al. | Mar 1988 | A |
4731079 | Stoy | Mar 1988 | A |
4731080 | Galin | Mar 1988 | A |
4764423 | Yamaguchi et al. | Aug 1988 | A |
4784485 | Ho | Nov 1988 | A |
4787903 | Grendahl | Nov 1988 | A |
4790847 | Woods | Dec 1988 | A |
4813956 | Gupta | Mar 1989 | A |
4816031 | Pfoff | Mar 1989 | A |
4836201 | Patton et al. | Jun 1989 | A |
4842601 | Smith | Jun 1989 | A |
4848343 | Wallsten et al. | Jul 1989 | A |
4888012 | Horn et al. | Dec 1989 | A |
4892543 | Turley | Jan 1990 | A |
4902293 | Feaster | Feb 1990 | A |
4913536 | Barnea | Apr 1990 | A |
4919151 | Grubbs et al. | Apr 1990 | A |
4932966 | Christie et al. | Jun 1990 | A |
4946469 | Sarfarazi | Aug 1990 | A |
4950289 | Krasner | Aug 1990 | A |
4963148 | Sulc et al. | Oct 1990 | A |
4994082 | Richards et al. | Feb 1991 | A |
4995879 | Dougherty | Feb 1991 | A |
4995880 | Galib | Feb 1991 | A |
5015254 | Greite | May 1991 | A |
5035710 | Nakada et al. | Jul 1991 | A |
5047051 | Cumming | Sep 1991 | A |
5061914 | Busch et al. | Oct 1991 | A |
5066301 | Wiley | Nov 1991 | A |
5078740 | Walman | Jan 1992 | A |
5145884 | Yamamoto et al. | Sep 1992 | A |
5145935 | Hayashi | Sep 1992 | A |
5151752 | Oono et al. | Sep 1992 | A |
5152789 | Willis | Oct 1992 | A |
5169920 | Okawa | Dec 1992 | A |
5171266 | Wiley et al. | Dec 1992 | A |
5200430 | Federman | Apr 1993 | A |
5201763 | Brady et al. | Apr 1993 | A |
5203788 | Wiley | Apr 1993 | A |
5213579 | Yamada et al. | May 1993 | A |
5224957 | Gasser et al. | Jul 1993 | A |
5235003 | Ward et al. | Aug 1993 | A |
5251993 | Sigourney | Oct 1993 | A |
5275623 | Sarfarazi | Jan 1994 | A |
5275624 | Hara et al. | Jan 1994 | A |
5288293 | O'donnell | Feb 1994 | A |
5290892 | Namdaran et al. | Mar 1994 | A |
5326347 | Cumming | Jul 1994 | A |
5391590 | Gerace et al. | Feb 1995 | A |
5405386 | Rheinish et al. | Apr 1995 | A |
5426166 | Usifer et al. | Jun 1995 | A |
5443506 | Garabet | Aug 1995 | A |
5444106 | Zhou et al. | Aug 1995 | A |
5444135 | Cheradame et al. | Aug 1995 | A |
5476514 | Cumming | Dec 1995 | A |
5489302 | Skottun | Feb 1996 | A |
5496366 | Cumming | Mar 1996 | A |
5506300 | Ward et al. | Apr 1996 | A |
5512609 | Yang | Apr 1996 | A |
5567365 | Weinschenk et al. | Oct 1996 | A |
5578081 | Mcdonald | Nov 1996 | A |
5585049 | Grisoni et al. | Dec 1996 | A |
5593436 | Langerman | Jan 1997 | A |
5607472 | Thompson | Mar 1997 | A |
5618903 | Hoxmeier | Apr 1997 | A |
5628795 | Langerman | May 1997 | A |
5633504 | Collins et al. | May 1997 | A |
5665822 | Bitler et al. | Sep 1997 | A |
5674282 | Cumming | Oct 1997 | A |
5676669 | Colvard | Oct 1997 | A |
5693095 | Freeman et al. | Dec 1997 | A |
5697973 | Peyman et al. | Dec 1997 | A |
5702441 | Zhou | Dec 1997 | A |
5774273 | Bornhorst | Jun 1998 | A |
5776191 | Mazzocco | Jul 1998 | A |
5776192 | Mcdonald | Jul 1998 | A |
5800533 | Eggleston et al. | Sep 1998 | A |
5843188 | Mcdonald | Dec 1998 | A |
5891931 | Leboeuf et al. | Apr 1999 | A |
5928282 | Nigam | Jul 1999 | A |
5964802 | Anello et al. | Oct 1999 | A |
5968095 | Norrby | Oct 1999 | A |
5984962 | Anello et al. | Nov 1999 | A |
6013101 | Israel | Jan 2000 | A |
6015842 | Leboeuf et al. | Jan 2000 | A |
6102539 | Tucker | Aug 2000 | A |
6117171 | Skottun | Sep 2000 | A |
6124980 | Cerbell | Sep 2000 | A |
6139576 | Doyle et al. | Oct 2000 | A |
6160084 | Langer et al. | Dec 2000 | A |
6176878 | Gwon et al. | Jan 2001 | B1 |
6180687 | Hammer et al. | Jan 2001 | B1 |
6188526 | Sasaya et al. | Feb 2001 | B1 |
6190410 | Lamielle et al. | Feb 2001 | B1 |
6195807 | Chou | Mar 2001 | B1 |
6197059 | Cumming | Mar 2001 | B1 |
6217612 | Woods | Apr 2001 | B1 |
6225367 | Chaouk et al. | May 2001 | B1 |
6229641 | Kosaka | May 2001 | B1 |
6299641 | Woods | Oct 2001 | B1 |
6302911 | Hanna | Oct 2001 | B1 |
6322589 | Cumming | Nov 2001 | B1 |
6342073 | Cumming et al. | Jan 2002 | B1 |
6348437 | Avery et al. | Feb 2002 | B1 |
6387126 | Cumming | May 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6406494 | Laguette et al. | Jun 2002 | B1 |
6413262 | Saishin et al. | Jul 2002 | B2 |
6423094 | Sarfarazi | Jul 2002 | B1 |
6436092 | Peyman | Aug 2002 | B1 |
6443985 | Woods | Sep 2002 | B1 |
6450642 | Jethmalani et al. | Sep 2002 | B1 |
6464725 | Skotton | Oct 2002 | B2 |
6488708 | Sarfarazi | Dec 2002 | B2 |
6493151 | Schachar | Dec 2002 | B2 |
6503276 | Lang et al. | Jan 2003 | B2 |
6517577 | Callahan et al. | Feb 2003 | B1 |
6528602 | Freeman et al. | Mar 2003 | B1 |
6551354 | Ghazizadeh et al. | Apr 2003 | B1 |
6552860 | Alden | Apr 2003 | B1 |
6554859 | Lang et al. | Apr 2003 | B1 |
6585768 | Hamano et al. | Jul 2003 | B2 |
6589550 | Hodd et al. | Jul 2003 | B1 |
6592621 | Domino | Jul 2003 | B1 |
6599317 | Weinschenk et al. | Jul 2003 | B1 |
6601956 | Jean et al. | Aug 2003 | B1 |
6610350 | Suzuki et al. | Aug 2003 | B2 |
6616691 | Tran | Sep 2003 | B1 |
6616692 | Glick et al. | Sep 2003 | B1 |
6638304 | Azar | Oct 2003 | B2 |
6638305 | Laguette | Oct 2003 | B2 |
6638306 | Cumming | Oct 2003 | B2 |
6645245 | Preussner | Nov 2003 | B1 |
6645246 | Weinschenk et al. | Nov 2003 | B1 |
6656223 | Brady | Dec 2003 | B2 |
6660035 | Lang et al. | Dec 2003 | B1 |
6692525 | Brady et al. | Feb 2004 | B2 |
6695881 | Peng et al. | Feb 2004 | B2 |
6709108 | Levine et al. | Mar 2004 | B2 |
6712848 | Wolf et al. | Mar 2004 | B1 |
6730123 | Klopotek | May 2004 | B1 |
6743388 | Sridharan et al. | Jun 2004 | B2 |
6749632 | Sandstedt et al. | Jun 2004 | B2 |
6749634 | Hanna | Jun 2004 | B2 |
6786934 | Zadno-Azizi et al. | Sep 2004 | B2 |
6818158 | Pham et al. | Nov 2004 | B2 |
6827738 | Willis et al. | Dec 2004 | B2 |
6836374 | Esch et al. | Dec 2004 | B2 |
6860601 | Shadduck | Mar 2005 | B2 |
6878320 | Alderson et al. | Apr 2005 | B1 |
6884261 | Zadno-Azizi et al. | Apr 2005 | B2 |
6899732 | Zadno-Azizi et al. | May 2005 | B2 |
6899850 | Haywood et al. | May 2005 | B2 |
6914247 | Duggan et al. | Jul 2005 | B2 |
6926736 | Peng et al. | Aug 2005 | B2 |
6935743 | Shadduck | Aug 2005 | B2 |
6949093 | Peyman | Sep 2005 | B1 |
6966649 | Shadduck | Nov 2005 | B2 |
6969403 | Peng et al. | Nov 2005 | B2 |
7001374 | Peyman | Feb 2006 | B2 |
7060094 | Shahinpoor et al. | Jun 2006 | B2 |
7068439 | Esch et al. | Jun 2006 | B2 |
7070276 | Koretz | Jul 2006 | B2 |
7074227 | Portney | Jul 2006 | B2 |
7122053 | Esch | Oct 2006 | B2 |
7144423 | Mcdonald | Dec 2006 | B2 |
7217288 | Esch et al. | May 2007 | B2 |
7241312 | Lai et al. | Jul 2007 | B2 |
7247168 | Esch et al. | Jul 2007 | B2 |
7247689 | Makker et al. | Jul 2007 | B2 |
7261737 | Esch et al. | Aug 2007 | B2 |
7264351 | Shadduck | Sep 2007 | B2 |
7276619 | Kunzler et al. | Oct 2007 | B2 |
7278739 | Shadduck | Oct 2007 | B2 |
7311194 | Jin et al. | Dec 2007 | B2 |
7354451 | Koch | Apr 2008 | B2 |
7378382 | Serobian et al. | May 2008 | B2 |
7416300 | Wei et al. | Aug 2008 | B2 |
7438723 | Esch | Oct 2008 | B2 |
7453646 | Lo | Nov 2008 | B2 |
7485144 | Esch | Feb 2009 | B2 |
7494505 | Kappelhof et al. | Feb 2009 | B2 |
7637947 | Smith et al. | Dec 2009 | B2 |
7675686 | Lo et al. | Mar 2010 | B2 |
7753953 | Yee | Jul 2010 | B1 |
7759408 | Schorzman et al. | Jul 2010 | B2 |
7763069 | Brady et al. | Jul 2010 | B2 |
7776088 | Shadduck | Aug 2010 | B2 |
7878655 | Salvati et al. | Feb 2011 | B2 |
7971997 | Hiramatsu et al. | Jul 2011 | B2 |
7988290 | Campbell et al. | Aug 2011 | B2 |
7988292 | Neal et al. | Aug 2011 | B2 |
7988293 | Raymond et al. | Aug 2011 | B2 |
8048155 | Shadduck | Nov 2011 | B2 |
8052752 | Woods et al. | Nov 2011 | B2 |
8158712 | Your | Apr 2012 | B2 |
8162927 | Peyman | Apr 2012 | B2 |
8241355 | Brady et al. | Aug 2012 | B2 |
8303656 | Shadduck | Nov 2012 | B2 |
8314927 | Choi et al. | Nov 2012 | B2 |
8328869 | Smiley et al. | Dec 2012 | B2 |
8361145 | Scholl et al. | Jan 2013 | B2 |
8377125 | Kellan | Feb 2013 | B2 |
8425599 | Shadduck | Apr 2013 | B2 |
8447086 | Hildebrand et al. | May 2013 | B2 |
8454688 | Esch et al. | Jun 2013 | B2 |
8480734 | Kellan et al. | Jul 2013 | B2 |
8523941 | Ichinohe et al. | Sep 2013 | B2 |
8574239 | Ichinohe et al. | Nov 2013 | B2 |
8613766 | Richardson et al. | Dec 2013 | B2 |
8632589 | Helmy | Jan 2014 | B2 |
8668734 | Hildebrand et al. | Mar 2014 | B2 |
8900298 | Anvar et al. | Dec 2014 | B2 |
8968396 | Matthews et al. | Mar 2015 | B2 |
9005282 | Chang et al. | Apr 2015 | B2 |
9034035 | Betser et al. | May 2015 | B2 |
9277987 | Smiley et al. | Mar 2016 | B2 |
9610155 | Matthews | Apr 2017 | B2 |
9855139 | Matthews et al. | Jan 2018 | B2 |
9872762 | Scholl et al. | Jan 2018 | B2 |
9872763 | Smiley et al. | Jan 2018 | B2 |
10980629 | Anvar et al. | Apr 2021 | B2 |
20010001836 | Cumming | May 2001 | A1 |
20010016771 | Cumming | Aug 2001 | A1 |
20010039449 | Johnson et al. | Nov 2001 | A1 |
20010051826 | Bogaert et al. | Dec 2001 | A1 |
20020046783 | Johnson et al. | Apr 2002 | A1 |
20020055777 | Cumming et al. | May 2002 | A1 |
20020072795 | Green | Jun 2002 | A1 |
20020095212 | Boehm | Jul 2002 | A1 |
20020107568 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020111678 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020116057 | Ting et al. | Aug 2002 | A1 |
20020116058 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020116059 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020116060 | Nguyen et al. | Aug 2002 | A1 |
20020116061 | Zadno-Azizi et al. | Aug 2002 | A1 |
20020133228 | Sarver | Sep 2002 | A1 |
20020161434 | Laguette et al. | Oct 2002 | A1 |
20020161435 | Portney | Oct 2002 | A1 |
20020177896 | Israel | Nov 2002 | A1 |
20020193876 | Lang et al. | Dec 2002 | A1 |
20030003295 | Dreher et al. | Jan 2003 | A1 |
20030004569 | Haefliger | Jan 2003 | A1 |
20030018384 | Valyunin et al. | Jan 2003 | A1 |
20030042176 | Alderson et al. | Mar 2003 | A1 |
20030050695 | Lin et al. | Mar 2003 | A1 |
20030050696 | Cumming | Mar 2003 | A1 |
20030060878 | Shadduck | Mar 2003 | A1 |
20030060881 | Glick et al. | Mar 2003 | A1 |
20030078656 | Nguyen | Apr 2003 | A1 |
20030078657 | Zadno-Azizi et al. | Apr 2003 | A1 |
20030078658 | Zadno-Azizi | Apr 2003 | A1 |
20030083744 | Khoury | May 2003 | A1 |
20030109925 | Ghazizadeh et al. | Jun 2003 | A1 |
20030109926 | Portney | Jun 2003 | A1 |
20030130732 | Sarfarazi | Jul 2003 | A1 |
20030135272 | Brady et al. | Jul 2003 | A1 |
20030149480 | Shadduck | Aug 2003 | A1 |
20030158599 | Brady et al. | Aug 2003 | A1 |
20030171808 | Phillips | Sep 2003 | A1 |
20030180522 | DeSimone | Sep 2003 | A1 |
20030183960 | Buazza et al. | Oct 2003 | A1 |
20030187505 | Liao | Oct 2003 | A1 |
20030199977 | Cumming | Oct 2003 | A1 |
20030236376 | Kindt-larsen et al. | Dec 2003 | A1 |
20040001180 | Epstein | Jan 2004 | A1 |
20040006386 | Valint et al. | Jan 2004 | A1 |
20040006387 | Kelman | Jan 2004 | A1 |
20040008419 | Schachar | Jan 2004 | A1 |
20040015236 | Sarfarazi | Jan 2004 | A1 |
20040039446 | Mcnicholas | Feb 2004 | A1 |
20040054408 | Glick et al. | Mar 2004 | A1 |
20040059343 | Shearer et al. | Mar 2004 | A1 |
20040066489 | Benedikt et al. | Apr 2004 | A1 |
20040082993 | Woods | Apr 2004 | A1 |
20040082994 | Woods et al. | Apr 2004 | A1 |
20040085511 | Uno et al. | May 2004 | A1 |
20040085515 | Roffman et al. | May 2004 | A1 |
20040088050 | Norrby et al. | May 2004 | A1 |
20040111151 | Paul et al. | Jun 2004 | A1 |
20040111152 | Kelman | Jun 2004 | A1 |
20040111153 | Woods et al. | Jun 2004 | A1 |
20040127984 | Paul et al. | Jul 2004 | A1 |
20040162612 | Portney et al. | Aug 2004 | A1 |
20040181279 | Nun | Sep 2004 | A1 |
20040230203 | Yaguchi | Nov 2004 | A1 |
20050021139 | Shadduck | Jan 2005 | A1 |
20050090612 | Soane et al. | Apr 2005 | A1 |
20050113911 | Peyman | May 2005 | A1 |
20050125000 | Tourrette et al. | Jun 2005 | A1 |
20050131535 | Woods | Jun 2005 | A1 |
20050165410 | Zadno-Azizi et al. | Jul 2005 | A1 |
20050251253 | Gross | Nov 2005 | A1 |
20050255231 | Hill et al. | Nov 2005 | A1 |
20050264756 | Esch | Dec 2005 | A1 |
20060069433 | Nun | Mar 2006 | A1 |
20060100703 | Evans et al. | May 2006 | A1 |
20060116763 | Simpson | Jun 2006 | A1 |
20060134173 | Liu et al. | Jun 2006 | A1 |
20060158611 | Piers et al. | Jul 2006 | A1 |
20060183041 | Erk et al. | Aug 2006 | A1 |
20060184181 | Cole et al. | Aug 2006 | A1 |
20060200167 | Peterson et al. | Sep 2006 | A1 |
20060241752 | Israel | Oct 2006 | A1 |
20060253196 | Woods | Nov 2006 | A1 |
20070004886 | Schorzman et al. | Jan 2007 | A1 |
20070005136 | Richardson | Jan 2007 | A1 |
20070021831 | Clarke | Jan 2007 | A1 |
20070027538 | Aharoni et al. | Feb 2007 | A1 |
20070050023 | Bessiere et al. | Mar 2007 | A1 |
20070078515 | Brady | Apr 2007 | A1 |
20070088433 | Esch et al. | Apr 2007 | A1 |
20070100445 | Shadduck | May 2007 | A1 |
20070106377 | Smith et al. | May 2007 | A1 |
20070118216 | Pynson | May 2007 | A1 |
20070129801 | Cumming | Jun 2007 | A1 |
20070156236 | Stenger | Jul 2007 | A1 |
20070162112 | Burriesci et al. | Jul 2007 | A1 |
20070203578 | Scholl et al. | Aug 2007 | A1 |
20070213817 | Esch et al. | Sep 2007 | A1 |
20070244561 | Ben nun | Oct 2007 | A1 |
20070260157 | Norrby | Nov 2007 | A1 |
20070282438 | Hong et al. | Dec 2007 | A1 |
20070299487 | Shadduck | Dec 2007 | A1 |
20080004699 | Ben Nun | Jan 2008 | A1 |
20080015689 | Esch et al. | Jan 2008 | A1 |
20080027537 | Gerlach et al. | Jan 2008 | A1 |
20080033449 | Cole et al. | Feb 2008 | A1 |
20080035243 | Breitenkamp et al. | Feb 2008 | A1 |
20080046074 | Smith et al. | Feb 2008 | A1 |
20080046075 | Esch et al. | Feb 2008 | A1 |
20080097460 | Boukhny et al. | Apr 2008 | A1 |
20080139769 | Iwamoto et al. | Jun 2008 | A1 |
20080179770 | Rooney et al. | Jul 2008 | A1 |
20080188930 | Mentak et al. | Aug 2008 | A1 |
20080200982 | Your | Aug 2008 | A1 |
20080243247 | Poley et al. | Oct 2008 | A1 |
20080269887 | Cumming | Oct 2008 | A1 |
20080300680 | Joshua | Dec 2008 | A1 |
20080306587 | Your | Dec 2008 | A1 |
20080306588 | Smiley et al. | Dec 2008 | A1 |
20090005865 | Smiley et al. | Jan 2009 | A1 |
20090027661 | Choi et al. | Jan 2009 | A1 |
20090030425 | Smiley et al. | Jan 2009 | A1 |
20090076602 | Ho et al. | Mar 2009 | A1 |
20090124773 | Zhou et al. | May 2009 | A1 |
20090149952 | Shadduck | Jun 2009 | A1 |
20090228101 | Zadno-Azizi | Sep 2009 | A1 |
20090234449 | De juan et al. | Sep 2009 | A1 |
20090248154 | Dell | Oct 2009 | A1 |
20090264998 | Mentak et al. | Oct 2009 | A1 |
20090281620 | Sacharoff et al. | Nov 2009 | A1 |
20090292293 | Bogaert et al. | Nov 2009 | A1 |
20090312836 | Pinchuk et al. | Dec 2009 | A1 |
20090319040 | Khoury | Dec 2009 | A1 |
20100016963 | Park | Jan 2010 | A1 |
20100022994 | Frey et al. | Jan 2010 | A1 |
20100039709 | Lo | Feb 2010 | A1 |
20100063588 | Park | Mar 2010 | A1 |
20100069522 | Linhardt et al. | Mar 2010 | A1 |
20100094412 | Wensrich | Apr 2010 | A1 |
20100131058 | Shadduck | May 2010 | A1 |
20100131061 | Callahan et al. | May 2010 | A1 |
20100161049 | Inoue | Jun 2010 | A1 |
20100179653 | Argento et al. | Jul 2010 | A1 |
20100228344 | Shadduck | Sep 2010 | A1 |
20100228346 | Esch | Sep 2010 | A1 |
20100324671 | Shadduck | Dec 2010 | A1 |
20100324672 | Esch et al. | Dec 2010 | A1 |
20110052020 | Hildebrand et al. | Mar 2011 | A1 |
20110118834 | Lo et al. | May 2011 | A1 |
20110153015 | Simonov et al. | Jun 2011 | A1 |
20110208301 | Anvar et al. | Aug 2011 | A1 |
20110282442 | Scholl et al. | Nov 2011 | A1 |
20110282443 | Smiley et al. | Nov 2011 | A1 |
20110288638 | Smiley et al. | Nov 2011 | A1 |
20110313522 | Hayes | Dec 2011 | A1 |
20110313523 | Hayes | Dec 2011 | A1 |
20120078363 | Lu | Mar 2012 | A1 |
20120078364 | Stenger | Mar 2012 | A1 |
20120116506 | Compertore | May 2012 | A1 |
20120179249 | Coleman | Jul 2012 | A1 |
20120221102 | Tanaka et al. | Aug 2012 | A1 |
20120226351 | Peyman | Sep 2012 | A1 |
20120245591 | Matthews | Sep 2012 | A1 |
20120253458 | Geraghty et al. | Oct 2012 | A1 |
20120253459 | Reich et al. | Oct 2012 | A1 |
20120303119 | Callahan et al. | Nov 2012 | A1 |
20130053954 | Rao et al. | Feb 2013 | A1 |
20130060331 | Shadduck | Mar 2013 | A1 |
20130103146 | Smiley et al. | Apr 2013 | A1 |
20130128368 | Costache et al. | May 2013 | A1 |
20130131794 | Smiley et al. | May 2013 | A1 |
20130250239 | Hildebrand et al. | Sep 2013 | A1 |
20130268070 | Esch et al. | Oct 2013 | A1 |
20140142587 | Walter et al. | May 2014 | A1 |
20140142588 | Hildebrand et al. | May 2014 | A1 |
20140249625 | Shadduck | Sep 2014 | A1 |
20150257874 | Hildebrand et al. | Sep 2015 | A1 |
20160038278 | Matthews | Feb 2016 | A1 |
20160113761 | Nishi et al. | Apr 2016 | A1 |
20170020662 | Shadduck | Jan 2017 | A1 |
20170049561 | Smiley et al. | Feb 2017 | A1 |
20170290658 | Hildebrand et al. | Oct 2017 | A1 |
20180028308 | Smiley et al. | Feb 2018 | A1 |
20180125640 | Smiley et al. | May 2018 | A1 |
20180132997 | Smiley et al. | May 2018 | A1 |
20180147051 | Scholl et al. | May 2018 | A1 |
20180153682 | Hajela et al. | Jun 2018 | A1 |
20180256315 | Hildebrand et al. | Sep 2018 | A1 |
Number | Date | Country |
---|---|---|
1283974 | Feb 2001 | CN |
1367667 | Sep 2002 | CN |
1378440 | Nov 2002 | CN |
1384727 | Dec 2002 | CN |
101039635 | Sep 2007 | CN |
101277659 | Oct 2008 | CN |
101547958 | Sep 2009 | CN |
102271622 | Dec 2011 | CN |
102010010430 | Sep 2011 | DE |
0898972 | Mar 1999 | EP |
2060243 | May 2009 | EP |
2192934 | Jun 2010 | EP |
2655841 | Jun 1991 | FR |
2784575 | Dec 2000 | FR |
05043699 | Feb 1993 | JP |
07-044938 | May 1995 | JP |
08-034855 | Feb 1996 | JP |
08-239479 | Sep 1996 | JP |
09-165449 | Jun 1997 | JP |
92-94754 | Nov 1997 | JP |
10-206609 | Aug 1998 | JP |
11-276509 | Oct 1999 | JP |
2008-307394 | Dec 2008 | JP |
1810052 | Apr 1993 | SU |
WO 1995002378 | Jan 1995 | WO |
WO 1997006751 | Feb 1997 | WO |
WO 2000041650 | Jul 2000 | WO |
WO 2000064655 | Nov 2000 | WO |
WO 2001060286 | Aug 2001 | WO |
WO 2001089435 | Nov 2001 | WO |
WO 2001097742 | Dec 2001 | WO |
WO 2002051338 | Jul 2002 | WO |
WO 2004010895 | Feb 2004 | WO |
WO 2004046768 | Jun 2004 | WO |
WO 2004072689 | Aug 2004 | WO |
WO 2005018504 | Mar 2005 | WO |
WO 2005084588 | Sep 2005 | WO |
WO 2006004707 | Jan 2006 | WO |
WO 2006047383 | May 2006 | WO |
WO 2006088440 | Aug 2006 | WO |
WO 2007005529 | Jan 2007 | WO |
WO 2007005692 | Jan 2007 | WO |
WO 2007030095 | Mar 2007 | WO |
WO 2007061688 | May 2007 | WO |
WO 2007128423 | Nov 2007 | WO |
WO 2007138564 | Dec 2007 | WO |
WO 2009015161 | Jan 2009 | WO |
WO 2009100322 | Aug 2009 | WO |
WO 2009154455 | Dec 2009 | WO |
WO 2011106435 | Sep 2011 | WO |
WO 2011119334 | Sep 2011 | WO |
WO 2012006186 | Jan 2012 | WO |
WO 2013142323 | Sep 2013 | WO |
Entry |
---|
JP-05043699-A—English translation (Year: 1993). |
CN-101547958-A, English translation (Year: 2009). |
U.S. Appl. No. 14/555,001, filed Nov. 26, 2021. |
U.S. Appl. No. 13/033,474, filed Feb. 23, 20211. |
Baughman et al. “Negative poisson's ratios for extreme states fo matter,” Science, vol. 288, pp. 2018-2022, Jun. 16, 2000. |
Baughman, “Avoiding the shrink,” Nature, vol. 425, p. 667, Oct. 16, 2003. |
Conlisk, A. T et al. “Mass Transfer and Flow in Electrically Charged Micro- and Nano-channels,” Analytical Chemistry, vol. 74; iss. 9; pp. 2139-2150; May 2002. |
Dubbelman et al. “The Thickness of the Aging Human Lens Obtained from Corrected Scheimpflug Images,” Optometry & Vision Science; vo. 78; iss. 6; pp. 411-416; Jun. 2001. |
Gorder, P. F.; Electricity can pump medicine in implanted medical devices; Ohio State Research News; 3 pgs.; May 2, 2002 (printed from internet Aug. 19, 2010). |
Gordon, “Applications of shape memory polyurethanes,” Proceedings of the First Intl Conf. on Shape Memory and Superelastic Tech., Asilomar Conference Center, Pacific Grove, CA, USA, pp. 115-120, Mar. 1994. |
Gruber et al. “Exhaustive soxhlet extraction for the complete removal of residual compounds,” Journal of Biomedical Materials Research, vol. 53; No. 5; pp. 445-448; Mar. 2000. |
Jeon et al., “Shape memory and nanostructure in poly(norbornyl-POSS) copolymers,” Polymer International, vol. 49, pp. 453-457, May 2000. |
Kim et al., “Polyurethanes having shape memory effects,” Polymer, vol. 37, No. 26, pp. 5781-5793, Dec. 1996. |
Lakes et al., “Dramatically stiffer elastic composite materials due to negative stiffness phase?,” Journal of the Mechanics and Physics of Solids, vol. 50, pp. 979-1009, May 2002. |
Lakes et al., “Extreme damping in composite materials with negative-stiffness inclusions,” Nature, vol. 410, pp. 565-567, Mar. 29, 2001. |
Lakes et al., “Microbuckling instability in elastomeric cellular sollids,” J. Materials Science, vol. 28, pp. 4667-4672, Jan. 1993. |
Lakes, “A broader view of membranes,” Nature, vol. 414, pp. 503-504, Nov. 29, 2001. |
Lakes, “Deformations in extreme matter,” Science; perspectives; vol. 288; No. 5473; pp. 1976-1977; Jun. 16, 2000. |
Lakes, “Extreme damping in compliant composites with a negative-stiffness phase,” Philosophical Magazine Letters, vol. 81, No. 2, pp. 95-100, Feb. 2001. |
Lakes, “Extreme damping in composite materials with a negative stiffness phase,” Physical Review Letters, vol. 86, No. 13, pp. 2897-2900, Mar. 26, 2001. |
Lakes, “Negative poisson's ratio materials,” Science, vol. 238, p. 551, Oct. 23, 1987. |
Lakes, “No contractile obligations,” Nature, vol. 358, pp. 713-714, Dec. 31, 1992. |
Langenbucher et al., “Computerized calculation scheme for toric intraocular lenses,” Acta Ophthalmologica Scandinavica, vol. 82, No. 3, pp. 270-276, Jun. 2004. |
Lendlein et al., “Biodegradable, elastic shape-memory polymers for potential biomedical applications”, Science; vol. 296; pp. 1673-1676; May 31, 2002. |
Lendlein et al., “Shape-memory polymers,” Angew. Chem. Int. Ed.; vol. 41; pp. 2034-2057; Jun. 2002. |
Li et al., “Crystallinity and morphology of segmented polyurethanes with different soft-segment length,” Journal of Applied Polymer Science, vol. 62, pp. 631-638, Oct. 1996. |
Liu et al., “Thermomechanical characterization of a tailored series of shape memory polymers,” Journal of Applied Medical Polymers, vol. 6, No. 2, Dec. 2002. |
Mather et al., “Strain recovery in POSS hybrid thermoplastics,” Polymer Preprints, vol. 41, No. 1, pp. 528-529, Feb. 2000. |
Matthews et al.; U.S. Appl. No. 14/637,171 entitled “Intraocular lens delivery systems and methods of use,” filed Mar. 3, 2015. |
Metcalfe et al., “Cold hibernated elastic memory foams for endovascular interventions,” Biomaterials, vol. 24, pp. 491-497, Feb. 2003. |
Qiao et al.; Bio-inspired accommodating fluidic intraocular lens; Optics Letters; vol. 34; No. 20; pp. 3214-3216; Oct. 15, 2009. |
Rosales et al.; Pentacam Scheimpflug Quantitativelmaging of the Crystalline Lens andlntraocular Lens; J. Refractive Surgery; vol. 25; pp. 421-428; May 2009. |
Shadduck, John; U.S. Appl. No. 14/675,245 entitled “Intraocular lens system and method for power adjustment,” filed Mar. 31, 2015. |
Smiley et al.; U.S. Appl. No. 15/064,482 entitled “Accommodating intraocular lenses and methods of use,” filed Mar. 8, 2016. |
Smiley et al.; U.S. Appl. No. 15/064,482 entitled “Accommodating intraocular lenses,” filed Mar. 8, 2016. |
Smith et al.; U.S. Appl. No. 15/000,783 entitled “Accommodating intraocular lens system having spherical aberration compensation and method,” filed Jan. 19, 2016. |
Takahashi et al., “Structure and properties of shape-memory polyurethane block copolymers,” Journal of Applied Polymer Science, vol. 60, pp. 1061-1069, May 1996. |
Tehrani et al. “Capsule measuring ring to predict capsular bag diameter and follow its course after foldable intraocular lens implantation,” J Cataract Refract Surg.; vol. 29; No. 11; pp. 2127-2134; Nov. 2003. |
Tobushi et al., “Thermomechanical properties of shape memory polymers of polyurethane series and their applications,” Journal de Physique IV, Colloque C1, vol. 6, pp. 377-384, Aug. 1996. |
Vass et al. “Prediction of pseudophakic capsular bag diameter based on biometric variables,” J Cataract Refract Surg.; vol. 25; pp. 1376-1381; Oct. 1999. |
Wang et al., “Deformation of extreme viscoelastic metals and composites,” Materials Science and Enginerring A, vol. 370, pp. 41-49, Apr. 15, 2004. |
Wang et al., “Extreme stiffness systems due to negative stiffness elements,” American Journal of Physics, vol. 72, No. 1, pp. 40-50, Jan. 2004. |
Wang et al., “Stable extremely-high-damping discrete viscoelastic systems due to native stiffness elements,” Applied Physics Letters, vol. 84, No. 22, pp. 4451-4453, May 31, 2004. |
Wyant et al.; “Basic Wavefront Aberration Theory for Optical Metrology,” Applied Optics and Optical Engineering, vol. XI, pp. 1, 28-39, Aug. 10, 1992. |
Xu et al., “Making negative poisson's ratio microstructures by soft lithography,” Advanced Materials, vol. 11, No. 14, pp. 1186-1189, Jun. 1999. |
Zhao, H et al., “The effect of chromatic dispersion on pseudophakic optical performance,” Br J Opthalmol, vol. 91, pp. 1225-1229, May 2, 2007. |
Number | Date | Country | |
---|---|---|---|
20210290371 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
61307354 | Feb 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14555001 | Nov 2014 | US |
Child | 17200047 | US | |
Parent | 13033474 | Feb 2011 | US |
Child | 14555001 | US |